午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Shanghai Yifei Biotechnology Co. , Ltd.

Firmenname:Shanghai Yifei Biotechnology Co. , Ltd.
Telefon:021-65675885
E-Mail:customer_service@efebio.com
Nationalit?t:China
URL: http://www.efebio.com
Produkte insgesamt:11974
83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

Produktkatalog

Osemozotan HCl137275-80-0C19H22ClNO5
Zifaxaban1378266-98-8C20H16ClN3O4S
Lodelcizumab1355338-54-3
Ulocuplumab1375830-34-4
Enoblituzumab1353485-38-7
Anetumab ravtansine1375258-01-7
Fletikumab1357158-22-5
M35411360628-91-6C23H17FN6O2
Vc-seco-DUBA1345681-58-4C65H75ClN12O17
Trazpiroben1352993-39-5C31H39N3O4
Tarextumab1359940-55-8
Emibetuzumab1365287-97-3
Golgicide A-21394285-50-7C17H14F2N2
MopidamolMopidamol13665-88-8C19H31N7O4
Spiroglumide137795-35-8
P505-15 Acetate1370261-98-5C21H27N9O3
(4R)-RO52633971357266-80-8C10H11FN2O
NS-102136623-01-3C12H11N3O4
Kv3 modulator 11380696-64-9C20H20N4O4
EW-71951352609-28-9C23H18N8
Pritoxaximab1351470-16-0
(+)-Picumeterol139423-79-3C21H29Cl2N3O2
Turosteride137099-09-3C27H45N3O3
2,3-Bis(3-indolylmethyl)indole138250-72-3
LPA1 receptor antagonist 11396006-71-5C28H26N4O4
DpC1382469-39-7C19H23N5S
UNC99951354030-52-6C20H21Cl2N3OS
ACT-4622061361321-96-1C20H24N2O4S
GSK2994231352149-24-6C25H27N5O2S
Enfortumab vedotin-ejfv1346452-25-2
Anatumomab mafenatox1370261-50-9
1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl-138801-72-6C23H20N2S
UNC00061354030-14-0C24H29Cl2N3O2
Idarucizumab1362509-93-0
THX-B1372206-64-8C16H24N6O4
Guselkumab1350289-85-8
TBK1/IKKε-IN-41381930-17-1C28H35N7O4
ME11111391758-52-3C12H14N2O
Tosatoxumab1374419-41-6
Diridavumab1393659-46-5
Nexopamil136033-49-3C24H40N2O3
Kukoamine B mesylate1375179-86-4C28H42N4O6.CH4O3S
8alpha-Hydroxyhirsutinolide1394156-45-6C15H20O6
Setoxaximab1351470-17-1
ONC1-13B1351185-54-0C22H16F4N4O3S
ADR-851 free base138559-56-5C14H18ClN3O2
CUR5g1370032-20-4C22H20N2O2
PI3K-IN-311359956-12-9C19H23F2N7O3
RTC131359825-94-7C14H9N3O4S
Varlilumab1393344-72-3
Obiltoxaximab1351337-07-9
Vantictumab1345009-45-1
Temelimab1393641-34-3
Atevirdine136816-75-6C21H25N5O2
DSPE-Mal1360858-99-6C48H87N2O11P
DSPE-NHS1383932-86-2C49H89N2O13P
Nolomirole HCl138531-51-8C19H28ClNO4
LY3020371 hydrochloride1377615-44-5C15 H15 F2 N O5 S . Cl H
MPT0B3921346169-92-3C19H20N2O6S
NorA-IN-11389310-69-3C18H18O5
Codrituzumab1365267-33-9
Margetuximab1350624-75-7
Fluorizoline1362243-70-6C15H8Cl2F3NS
Antioxidant agent-1136068-43-4C15H12O3
CGP-20712137888-49-4C23H25F3N4O5
UNC99751354030-19-5C23H28Cl2N4O2
MIV-2471352817-76-5C17H24F3N3O4
Aptiganel137159-92-3C20H21N3
D-Glucose-1,2-13C2138079-87-5C6H12O6
Fosopamine(HCl)135962-35-5C9H14NO5P.ClH
γ-Secretase modulator 131353570-40-7C22H23FN6S
Nebacumab138661-01-5
(2RS)-FPMPA135295-27-1C9H13FN5O4P
GAL-021 sulfate1380342-00-6C11H24N6O5S
AMG-16941361217-07-3C23H30F3N3O4S2
Sigma-LIGAND-1 hydrochloride139652-86-1C27H34ClNO4
Nisin Z137061-46-2C141H229N41O38S7
Furnidipine138661-03-7C21H24N2O7
KP-4571365803-52-6C21H24N2O7S2
Diphlorethohydroxycarmalol138529-04-1C24H16O13
FL118135415-73-5C21H16N2O6
Sevirumab138660-96-5
MpsBAY2a1382477-96-4C29H28N6O
Sophoraflavanone H136997-68-7C34H30O9
TG-2-IN-1135273-74-4C8H13ClN2OS
DHODH-IN-231346705-53-0C24H21ClFNO4
Iliparcil137214-72-3C16H18O6S
CPI-0610 carboxylic acid1380089-81-5C20H15ClN2O3
Anti-amyloid agent-11396778-73-6C21H17F3N2O3
Cassiaside13709-03-0C20H20O10
SCFSkp2-IN-21375060-02-8C17H20N4O2
Golgicide A-11394285-49-4C17H14F2N2
CP 96021139401-43-7C29H21FN4OS
IHVR-110291383152-30-4C18H27F2NO5
UBE2T/FANCL-IN-11359415-02-3C19H31N7
PI3K-IN-381382979-64-7C20H24N6O2
Tuvirumab138660-97-6
OTS4471356943-67-3C27H32ClN3O2
ERD031377897-01-2C21H25NO3
NSC639828134742-26-0C18H13BrClN5O3
83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2019 ? ChemicalBook. All rights reserved